FDA approves Lynparza for hereditary breast cancer linked to BRCA mutations
The FDA approves AstraZeneca Merck Lynparza for women with advanced BRCA mutation linked breast cancer. The PARP inhibitor delays progression, costs 13886 per month without insurance, and comes with a companion Myriad blood test to identify eligible patients.
MENTIONED IN THIS ARTICLE
U.S
Ufma
Food and Drug Administration
AstraZeneca PLC
Lynparza
AstraZeneca
Susan Domchek
University of Pennsylvania
Abramson
FDA
Richard Pardur
Myriad Sense
National Cancer Institute
Merck & Co
Kenilworth
New Jersey
Wind Baton Rouge Report From Pau Wee Viocvenay
A brief weather blurb notes wind conditions near Pau Wee Viocvenay with gusts under three miles per hour amid snowfall. The terse item records light wind shortly before snowfall continues, with no additional climate details or hazards.
Tax reform sparks business growth and large bonuses
Tax reform discussed as a growth catalyst with Fiat planning a 1 billion dollar Michigan plant investment and 60 000 workers to receive 2000 bonuses. Walmart pledges higher wages bonuses and expanded parental leave benefiting over 1 million employees. Experts note lower corporate rates and pass through deductions but warn of added complexity and new interest deduction limits. Local firms cautious on immediate impact.
MENTIONED IN THIS ARTICLE
Fiat
Michigan
U.S
Haans Mulder
Cunningham Dalman
Holland
Mulder
Walmart
Doug McMillon
West Michigan
Also Mentioned on This Page
Holland Workshops
James Street
Davidcarrierlaw.com
David Carrier PC
David L. Carrier, P.C
David Carrier
Pau Wee
Chicago
Burlington
Des Plaines
Oak Lawn
Tintey Park
Albuquerque
Anchorage
Cheveland
P.m. San
Kansas City
Las Vegas
Los Angeles
New Orleans
New York City
Portland
Francisco
Accuieather Inc
Seattle
AccuWeather
Wash
India
Bam
San Bernardino
SentinelJake
SentinelAustin
BizHolland
Associated Press
US Talis
Jobs Act
Paul Ryan
Wis
Capitol Hill
Washington
House
Kevin Brady
Texas
Cathy McMorris Rodgers
Jacquelyn Martin